Infant Bacterial Therapeutics AB (9IB.F) Q1 2026 Earnings

Feb 6Confirmed
Q4 2025
Q1 2026
-0.13
-0.11
-0.09
-0.07

Details

Expected EPS
N/A
Actual EPS
-0.1309291412
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Infant Bacterial Therapeutics AB⁩ (⁦9IB.F⁩) has reported earnings of ⁦-0.1309291412⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts